DEA Raids Las Vegas Biolab: $312 Billion Laundering Operation and Fake FDA Test Scheme Exposed — Kristi Orders Immediate Arrests

In a stunning series of events, federal agents have raided a Las Vegas biolab at the center of one of the most extensive and sophisticated criminal operations ever uncovered. The biolab, which has been operating under the radar for years, was found to be moving $312 billion through intricate financial structuring designed to evade detection and regulatory oversight.

But that’s not all. The biolab was also at the heart of a massive fraudulent medical testing scheme, where diagnostic kits were falsely marketed as FDA-approved, deceiving countless consumers and medical professionals. The sheer scale of the operation has left officials stunned, raising the question: How did such a vast network operate undetected for so long?

Kristi, the lead federal agent overseeing the case, has issued immediate arrest orders for key figures within the biolab, with authorities seizing mountains of fraudulent medical products, sophisticated financial records, and high-tech equipment designed to launder ill-gotten gains and skirt regulatory scrutiny.

As investigators comb through the facility, it’s clear that the scope of this operation is far-reaching. The financial networks uncovered are complex and highly advanced, involving shell companies, offshore accounts, and a vast network of accomplices. The regulatory evasion was carefully planned, with fake test results and misleading marketing tactics targeting both individual consumers and large healthcare systems.

Officials warn that this could be just the tip of the iceberg, as the true extent of the operation may not be fully revealed for months or even years. The medical industry, already reeling from a wave of scandals in recent years, now faces another blow as investigators race to uncover the full scope and impact of the biolab’s influence.

Federal oversight systems are already on high alert, and with Kristi’s team leading the charge, the unraveling of this fraud could bring far-reaching consequences across the healthcare sector.